“RECENT UPDATE ON PYRIMIDINE DERIVATIVES AS POTENTIAL DPP-IV INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS”. Journal of Pharmaceutical Negative Results (December 28, 2022): 5734–5743. Accessed June 11, 2026. https://www.pnrjournal.com/index.php/home/article/view/5581.